Abstract View: 1604
PDF Download: 952
Editorial
Controversy with bromhexine in COVID-19; where we stand
Ramin Tolouian
1* 
, Zuber D. Mulla
2 1 Division of Nephrology, University of Arizona, Tucson, AZ, USA
2 Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA, and Julia Jones Matthews Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, TX, USA
Citation: Tolouian R , Mulla ZD. Controversy with bromhexine in COVID-19; where we stand. Immunopathol Persa. 2021;7(2):e12. DOI:10.34172/ ipp.2021.12.
Abstract View: 1605
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2024 | 72 | 65 | 66 | 68 | 39 | | | | | | | |
| 2023 | 37 | 31 | 32 | 22 | 4 | 29 | 38 | 54 | 73 | 86 | 72 | 59 |
| 2022 | 47 | 56 | 46 | 39 | 23 | 32 | 35 | 30 | 34 | 37 | 26 | 35 |
| 2021 | | | | | | | 34 | 68 | 78 | 67 | 27 | 44 |
PDF Download: 952
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2024 | 25 | 42 | 25 | 28 | 15 | | | | | | | |
| 2023 | 45 | 27 | 25 | 19 | 2 | 28 | 28 | 39 | 32 | 40 | 42 | 37 |
| 2022 | 25 | 20 | 16 | 20 | 20 | 16 | 22 | 22 | 41 | 29 | 37 | 40 |
| 2021 | | | | | | | 12 | 38 | 43 | 23 | 14 | 15 |